Texas Notifiable Conditions

24/7 Immediate Reporting Lines


City of Lubbock Health Department - 806.775.2935
State of Texas - 1.800.705.8868

Report confirmed and suspected cases.

Unless noted by *, report to your local or regional health department using the number above.

A – I

When to Report

L – Y

When to Report

*Acquired immune deficiency syndrome (AIDS)1, 2

Within 1 week

*Lead, child blood, any level & adult blood, any level3

Call/Fax Immediately

Amebiasis4

Within 1 week

Legionellosis4

Within 1 week

Amebic meningitis and encephalitis4

Within 1 week

Leishmaniasis4

Within 1 week

Anaplasmosis4

Within 1 week

Listeriosis4, 5

Within 1 week

Anthrax4, 5

Call Immediately

Lyme disease4

Within 1 week

Arbovirus infection4

Within 1 week

Malaria4

Within 1 week

*Asbestosis6

Within 1 week

Measles (rubeola)4

Call Immediately

Babesiosis4

Within 1 week

Meningococcal infections, invasive4, 5

Call Immediately

Botulism (adult and infant)4, 5, 7

Call Immediately

Multidrug-resistant Acinetobacter (MDR-A)8

Call Immediately

Brucellosis4, 5

Within 1 work day

Mumps4

Within 1 week

Campylobacteriosis4

Within 1 week

Pertussis4

Within 1 work day

*Cancer9

See rules9

*Pesticide poisoning, acute occupational10

Within 1 week

Carbapenem-resistant Enterobacteriaceae (CRE)11

Call Immediately

Plague (Yersinia pestis) 4, 5

Call Immediately

Chagas’ disease4

Within 1 week

Poliomyelitis, acute paralytic4

Call Immediately

*Chancroid1

Within 1 week

Poliovirus infection, non-paralytic4

Within 1 work day

Chickenpox (varicella)12

Within 1 week

Q fever4

Within 1 work day

*Chlamydia trachomatis infection1

Within 1 week

Rabies, human4

Call Immediately

*Contaminated sharps injury13

Within 1 month

Relapsing fever4

Within 1 week

*Controlled substance overdose14

Call Immediately

Rubella (including congenital)4

Within 1 work day

Coronavirus, novel causing severe acute respiratory disease 3, 15

Call Immediately

Salmonellosis, including typhoid fever4

Within 1 week

Creutzfeldt-Jakob disease (CJD)4, 16

Within 1 week

Shigellosis4

Within 1 week

Cryptosporidiosis4

Within 1 week

*Silicosis17

Within 1 week

Cyclosporiasis4

Within 1 week

Smallpox4

Call Immediately

Cysticercosis4

Within 1 week

*Spinal cord injury19

Within 10 work days

*Cytogenetic results (fetus and infant only)18

See rules18

Spotted fever group rickettsioses3

Within 1 week

Dengue4

Within 1 week

Staph. aureus, vancomycin-resistant (VISA and VRSA) 4, 5

Call Immediately

Diphtheria4

Call Immediately

Streptococcal disease (group A, B, S. pneumo), invasive4

Within 1 week

*Drowning/near drowning19

Within 10 work days

*Syphilis – primary and secondary stages 1, 20

Within 1 work day

Ehrlichiosis4

Within 1 week

*Syphilis – all other stages1, 20

Within 1 week

Escherichia coli infection, Shiga toxin-producing4, 5

Within 1 week

Taenia solium and undifferentiated Taenia infection4

Within 1 week

*Gonorrhea1

Within 1 week

Tetanus4

Within 1 week

Haemophilus influenzae type b infections, invasive4

Within 1 week

*Traumatic brain injury19

Within 10 work days

Hansen’s disease (leprosy) 4

Within 1 week

Trichinosis3

Within 1 week

Hantavirus infection4

Within 1 week

Tuberculosis disease5, 21

Within 1 work day

Hemolytic Uremic Syndrome (HUS) 4

Within 1 week

Tuberculosis infection22

Within 5 work days

Hepatitis A (acute)4

Within 1 work day

Tularemia4, 5

Call Immediately

Hepatitis B, C, and E (acute) 4

Within 1 week

Typhus4

Within 1 week

Hepatitis B identified prenatally or at delivery (acute & chronic) 4

Within 1 week

Vibrio infection, including cholera4, 5

Within 1 work day

Hepatitis B, perinatal (HBsAg+ < 24 months old) 4

Within 1 work day

Viral hemorrhagic fever, including Ebola4

Call Immediately

*Human immunodeficiency virus (HIV) infection1, 2

Within 1 week

Yellow fever4

Call Immediately

Influenza-associated pediatric mortality4

Within 1 work day

Yersiniosis4

Within 1 week

Influenza, Novel4

Call Immediately

 

In addition to specified reportable conditions, any outbreak, exotic disease, or unusual group expression of disease that may be of public health concern should be reported by the most expeditious means available

.

 *See condition-specific footnote for reporting contact information
1. Please refer to specific rules and regulations for HIV/STD reporting and who to report to at: http://www.dshs.state.tx.us/hivstd/healthcare/reporting.shtm.
2. Labs conducting confirmatory HIV testing are requested to send remaining specimen to a CDC-designated laboratory. Please call 512-533-3132 for details.

3. For reporting information see http://www.dshs.state.tx.us/lead/default.shtm.
4. Reporting forms are available at http://www.dshs.state.tx.us/idcu/investigation/forms/ and investigation forms at http://www.dshs.state.tx.us/idcu/investigation/. Call as indicated for immediately reportable conditions.

5. Lab isolate must be sent to DSHS lab. Call 512-776-7598 for specimen submission information.

6. For reporting information see http://www.dshs.state.tx.us/epitox/asbestosis.shtm.

7. Report suspected botulism immediately by phone to 888-963-7111.

8. See additional reporting information at http://www.dshs.state.tx.us/IDCU/health/antibiotic_resistance/MDR-A-Reporting.doc.
9. Please refer to specific rules and regulations for cancer reporting and who to report to at http://www.dshs.state.tx.us/tcr/reporting.shtm.

10. For reporting information see http://www.dshs.state.tx.us/epitox/Pesticide-Exposure/%23reporting#reporting

11. See additional reporting information at http://www.dshs.state.tx.us/IDCU/health/antibiotic_resistance/Reporting-CRE.doc.
12.  Call your local health department for a copy of the Varicella Reporting Form with their fax number. The Varicella (chickenpox) Reporting Form should be used instead of an Epi-1 or Epi-2 morbidity report.  

 13. Not applicable to private facilities. Initial reporting forms for Contaminated Sharps at http://www.dshs.state.tx.us/idcu/health/infection_control/bloodborne_pathogens/reporting/.
14. Contact local poison center at 1-800-222-1222. For instructions, see http://www.dshs.state.tx.us/epidemiology/epipoison.shtm#rcso.
15. Novel coronavirus causing severe acute respiratory disease includes previously reportable Severe Acute Respiratory Syndrome (SARS).
16. For purposes of surveillance, CJD notification also includes Kuru, Gerstmann-Sträussler-Scheinker (GSS) disease, fatal familial insomnia (FFI), sporadic fatal insomnia (sFI), Variably Protease-Sensitive Prionopathy (VPSPr) and any novel prion disease affecting humans.

17. For reporting information see http://www.dshs.state.tx.us/epitox/silicosis.shtm.
18. Report cytogenetic results including routine karyotype and cytogenetic microarray testing (fetus and infant only). Please refer to specific rules and regulations for birth defects reporting and who to report to at http://www.dshs.state.tx.us/birthdefects/BD_LawRules.shtm.
19. Please refer to specific rules and regulations for injury reporting and who to report to at http://www.dshs.state.tx.us/injury/rules.shtm.

20. Laboratories should report syphilis test results within 3 work days of the testing outcome.
21. Reportable tuberculosis disease includes the following: suspected tuberculosis disease pending final laboratory results; positive nucleic acid amplification tests; clinically or laboratory-confirmed tuberculosis disease; and all Mycobacterium tuberculosis (M.tb) complex including M. tuberculosis, M. bovis, M. africanum, M. canettii, M. microti, M. caprae, and M. pinnipedii. See rules at http://www.dshs.state.tx.us/idcu/disease/tb/reporting/.
22. Reportable tuberculosis infection includes the following: a positive result from an Interferon-Gamma Release Assay (IGRA) test such as T-SPOT®.TB or QuantiFERON®- TB Gold In-Tube (QFT-G) or a tuberculin skin test (TST) plus a normal chest x-ray and asymptomatic. 

 

Expires 1/31/16 -- Go to http://www.dshs.state.tx.us/idcu/investigation/conditions/ or call your local or regional health department for updates.